Clinical Trial Update: Pilot Study of IFN α2b for Melanoma Patients [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot trial of interferon alfa-2b in melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: University of Pittsburgh | Conditions: Melanoma | EARLY_Phase 1 | Status: TERMINATED